The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities
First Affiliated Hospital of Wenzhou Medical University
First Affiliated Hospital of Wenzhou Medical University
Sun Yat-sen University
Duke University
British Columbia Cancer Agency
Duke University
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University of Rochester
M.D. Anderson Cancer Center
Duke University
University of Manitoba
University of South Florida
M.D. Anderson Cancer Center